Determination of debrisoquine and metabolites in human urine by gas chromatography—mass spectrometry
- 18 September 1991
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 570 (1), 89-97
- https://doi.org/10.1016/0378-4347(91)80203-o
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The genetic polymorphism of sparteine metabolismXenobiotica, 1986
- Defective Oxidation of DrugsClinical Pharmacokinetics, 1982
- A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Journal of Medical Genetics, 1980
- Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquineEuropean Journal of Clinical Pharmacology, 1980
- Debrisoquin hydroxylation polymorphism among Ghanaians and CaucasiansClinical Pharmacology & Therapeutics, 1979
- The metabolism of [14C]‐debrisoquine in man.British Journal of Clinical Pharmacology, 1979
- Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamineXenobiotica, 1979
- Defective N-oxidation of sparteine in man: A new pharmacogenetic defectEuropean Journal of Clinical Pharmacology, 1979
- Polymorphism of carbon oxidation of drugs and clinical implications.BMJ, 1978
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977